Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Smith V currently holds 66,350 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Smith V has been a net seller of OGXI stock. They have purchased $0 and sold $1.4M worth of shares.
David Smith V's most recent insider trade was on Jun 17, 2026, when they sold 66,350 shares at $0.00 per share.
David Smith V serves as Executive at ONCOGENEX PHARMACEUTICALS, INC. (OGXI). They have executed 57 insider transactions totaling $1.4M over their tenure at the company.
David Smith V holds the position of Executive at ONCOGENEX PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
David Smith V has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Smith V was on Apr 16, 2021, when they sold $5.3M worth of FPRX shares. This transaction involved 138,947 shares at $38.00 per share.
David Smith V currently owns 66,350 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Smith V's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Smith V has 57 Form 4 filings on record as an insider at ONCOGENEX PHARMACEUTICALS, INC..
Set alerts for David Smith V and 40,000+ other insiders.